APA (7th ed.) Citation

Desilets, A., Repetto, M., & Drilon, A. (2024). Repotrectinib: Redefining the therapeutic landscape for patients with ROS1 fusion‐driven non‐small cell lung cancer. Clinical & Translational Medicine, 14(10), 1. https://doi.org/10.1002/ctm2.70017

Chicago Style (17th ed.) Citation

Desilets, Antoine, Matteo Repetto, and Alexander Drilon. "Repotrectinib: Redefining the Therapeutic Landscape for Patients with ROS1 Fusion‐driven Non‐small Cell Lung Cancer." Clinical & Translational Medicine 14, no. 10 (2024): 1. https://doi.org/10.1002/ctm2.70017.

MLA (9th ed.) Citation

Desilets, Antoine, et al. "Repotrectinib: Redefining the Therapeutic Landscape for Patients with ROS1 Fusion‐driven Non‐small Cell Lung Cancer." Clinical & Translational Medicine, vol. 14, no. 10, 2024, p. 1, https://doi.org/10.1002/ctm2.70017.